Creating New Decentralized Clinical Trial Ecosystem Including Bring Your Own Physician Option with Tom Lemberg Curebase
January 18, 2022
Tom Lemberg is the Founder and CEO of Curebase and was recently included in the Forbes 30 under 30 list for 2022 for leading positive global change in healthcare. Curebase is shaking up the world of clinical trials by providing software for patients making it easy for them to participate from home, software for doctors that makes it easy for them to participate in the research, along with a virtual research site model that has grown even more valuable due to the pandemic.
Tom explains, "In terms of what Curebase does, we're a full platform for what's called a decentralized clinical trial. So, that means taking trials out of the elite institutions and bringing them to patients at home. We have an app for patients which guides them through things like discovering trials, submitting data at home, connecting medical records, scheduling telemedicine appointments, conducting telemedicine appointments, and participating in treatments from home."
"We also have software for physicians. So we've brought over 100 community physicians, so sort of first-time researchers, into the clinical trial world using our software to make it easy for them to participate."
"Through the software and our virtual site model, we've really reduced the barriers to participation for patients and doctors, and that's what gets us into the idea of Bring Your Own Physician. So, Bring Your Own Physician is something that we're really pioneering. It's the idea that a patient could discover a clinical trial on the internet, sign up at home using our app or any other technology, and they could then participate with their own doctor."
At Curebase, our mission is to bring quality medical innovations to patients faster and improve human wellbeing through more efficient clinical studies. We are proving that clinical research can be radically accelerated if we empower physicians everywhere to enroll patients in the communities where they live. By applying cutting edge clinical software and remote study management techniques to the problem, we are reinventing clinical trials and research from the ground up.